HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Recommendation For OTC Buprenorphine Joins Opioid Abuse Epidemic Discussion

Executive Summary

Boston University researchers recommend allowing pharmacists to dispense buprenorphine without prescriptions to expand access among the 2m consumers with opioid use disorder and help reduce the estimated 130 overdose deaths each day in the US. "It is important to attempt to address the opioid epidemic in new, effective, and safe ways. Increasing access to buprenorphine, a relatively safe medication, without a prescription could prove helpful for treating persons with OUD," say Payel Jhoom Roy and Michael Stein.

Related Content

Before Asking FDA For Novel OTC Switch, Be Sure DFL Alone 'Can't Get There'
To Curb PSE Diversion, Retailers Lead By Example With Emphasis On Tamper-Resistant Products
FDA Drops Access Restrictions On Generic OTC Emergency Contraceptives





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts